化合物BMS-191011 T7512
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
1 mg | 202821-81-6 | ¥195.00 | 询底价 |
25 mg | 202821-81-6 | ¥1,530.00 | 询底价 |
50 mg | 202821-81-6 | ¥2,970.00 | 询底价 |
5 mg | 202821-81-6 | ¥496.00 | 询底价 |
1 mL | 202821-81-6 | ¥546.00 | 询底价 |
2 mg | 202821-81-6 | ¥285.00 | 询底价 |
100 mg | 202821-81-6 | ¥4,380.00 | 询底价 |
10 mg | 202821-81-6 | ¥745.00 | 询底价 |
Product Introduction
Bioactivity
英文名: BMS-191011
描述: BMS-191011 (BMS-A) 是一种大电导 Ca2+激活的钾通道 (Ca2+-activated potassium (maxi-K) channel) 激活剂,在中风模型中有研究价值。
体内活性: In vivo, BMS 191011 (10-100 μg/kg, i.v.) increases the diameter of retinal arterioles without affecting blood pressure or heart rate in rats, an effect that is reversed by the BKCa channel blocker iberiotoxin[1]
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 125 mg/mL (337.19 mM)
关键字: Potassium Channel | rodent models of stroke | Panc-1 | neuroprotective activity | inhibit | IGR39 | BMS-191011 | Inhibitor | BMS 191011 | BMS191011 | KcsA
相关产品: Topiramate | VU6036720 | Thevetin B | CLP290 | BAPTA-AM | Bupivacaine hydrochloride monohydrate | CLP257 | Reserpine | TWIK-1/TREK-1-IN-1 | SCH-23390 maleate
相关库: Ion Channel Inhibitor Library | Potassium Channel Blocker Library | Anti-Cancer Compound Library | Membrane Protein-targeted Compound Library | Bioactive Compounds Library Max | Target-Focused Phenotypic Screening Library | Bioactive Compound Library
化合物BMS-191011 T7512信息由TargetMol中国为您提供,如您想了解更多关于化合物BMS-191011 T7512报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途